News Listing

News Listing

Study shows high prevalence of knee osteoarthritis in Vietnam

Study shows high prevalence of knee osteoarthritis in Vietnam

MEDIA RELEASE: Apr 11, 2014 07:00 AM
A study undertaken in Vietnam for the first time reveals the high prevalence of knee osteoarthritis, showing that roughly a third of Vietnamese men and women over the age of 40 are affected.

More…

Rolling out the red carpet for inspiring biomedical animation

Rolling out the red carpet for inspiring biomedical animation

MEDIA RELEASE: Apr 10, 2014 06:00 AM
Three biomedical animations will be premiered today at Melbourne’s spectacular glass-walled Deakin Edge theatre in Federation Square, prior to being made available for television broadcast and online education.

More…

Mark Cowley and Marina Pajic top-ranked applicants for Cancer Institute NSW Fellowships

Mark Cowley and Marina Pajic top-ranked applicants for Cancer Institute NSW Fellowships

Apr 08, 2014 09:00 AM
Dr Marina Pajic and Dr Mark Cowley from Garvan were awarded Cancer Institute NSW Fellowships this year, each ranked as top applicant in their category, a Career Development Fellowship and Early Career Fellowship respectively.

More…

Calvin Leung wins University Medal in Neuroscience at UNSW Australia

Calvin Leung wins University Medal in Neuroscience at UNSW Australia

Mar 27, 2014 02:00 PM
Congratulations to Calvin Leung, who has won the 2013 University Medal in Neuroscience at UNSW Australia. Calvin undertook his honours project throughout 2013 in Dr Greg Neely’s Functional Genomics Laboratory at Garvan.

More…

A versatile mouse that can teach us about many diseases and drugs

A versatile mouse that can teach us about many diseases and drugs

MEDIA RELEASE: Mar 14, 2014 03:00 AM
Garvan and UK researchers have created a mouse that expresses a fluorescing ‘biosensor’ in every cell of its body, allowing diseased cells and drugs to be tracked and evaluated in real time and in three dimensions.

More…

Garvan led team wins prestigious prostate cancer award

Garvan led team wins prestigious prostate cancer award

MEDIA RELEASE: Mar 13, 2014 09:00 AM
An international team, led by Professor Peter Croucher from Garvan, today received one of two 2014 Movember Revolutionary Team Awards from the Prostate Cancer Foundation of Australia (PCFA).

More…

Overwhelming response for Ovarian Cancer Awareness Day Leader’s Lunch

Overwhelming response for Ovarian Cancer Awareness Day Leader’s Lunch

Feb 28, 2014 12:38 PM
For the third year, Garvan marked Ovarian Cancer Awareness Day with a gathering of supporters, media and those working toward improving outcomes for women diagnosed with this devastating disease.

More…

Garvan celebrates the generosity of its corporate supporters

Garvan celebrates the generosity of its corporate supporters

Feb 11, 2014 02:28 PM
To launch the working year, the Garvan Research Foundation Chairman, Mr Geoff Dixon formally acknowledged the generous support of Garvan’s corporate supporters at an event celebrating outstanding work in the field of employee engagement, Corporate Social Responsibility (CSR) and campaign management.

More…

Slowing down the immune system when in overdrive

Slowing down the immune system when in overdrive

MEDIA RELEASE: Feb 11, 2014 12:05 AM
Many people suffer from chronic inflammation because their immune systems overreact to ‘self’ tissue. Garvan scientists believe that a small molecule known as Interleukin 21 is a promising therapeutic target in such cases.

More…

Evidence that shivering and exercise may convert white fat to brown

Evidence that shivering and exercise may convert white fat to brown

MEDIA RELEASE: Feb 05, 2014 04:00 AM
A new study suggests that shivering and bouts of moderate exercise are equally capable of stimulating the conversion of energy-storing ‘white fat’ into energy-burning ‘brown fat’. This makes brown fat a potential therapeutic target against obesity and diabetes.

More…

Muscle is three times better than fat for bones

Muscle is three times better than fat for bones

MEDIA RELEASE: Jan 20, 2014 08:05 AM
Garvan researchers in collaboration with Vietnamese colleagues have now shown that the impact of ‘lean mass’ is 3 times higher than the impact of ‘fat mass’, finally concluding a debate that has lasted for over 20 years.

More…

The future of genomic medicine has arrived in Australia

The future of genomic medicine has arrived in Australia

MEDIA RELEASE: Jan 15, 2014 03:00 AM
The transformation of medicine by human genome sequencing has moved closer following the announcement today that Sydney’s Garvan Institute of Medical Research is one of the first in the world to acquire machines that can sequence a whole human genome at a base cost below $US1,000.

More…

NHMRC Recognises John Mattick, John Shine and Peter Wills

NHMRC Recognises John Mattick, John Shine and Peter Wills

Jan 14, 2014 03:26 PM
Researchers chosen by the NHMRC’s Internal Scientific Planning Group and a Scientific Steering Committee, following public consultation.

More…

How fat might be controlled through the body clock

How fat might be controlled through the body clock

MEDIA RELEASE: Jan 08, 2014 04:00 PM
Garvan researchers have shed more light on an underexplored aspect of the important brain-signaling system that controls appetite, body composition and energy use. Their findings suggest that a specific gene regulating our body clock may play a central role in determining how fat we become.

More…

David Thomas appointed as new Director of The Kinghorn Cancer Centre

David Thomas appointed as new Director of The Kinghorn Cancer Centre

MEDIA RELEASE: Dec 19, 2013 12:00 AM
Garvan is very pleased to announce the appointment of Professor David Thomas as the new Director of The Kinghorn Cancer Centre, as well as Head of Garvan’s Cancer Division, from July 2014. The Kinghorn Cancer Centre is a joint venture of Garvan and St Vincent’s Hospital that brings together the scientific and medical expertise of the two partners to provide a personalised medicine approach to the treatment and care of cancer patients.

More…

Neil Watkins assumes Petre Foundation Chair of Cancer Biology

Neil Watkins assumes Petre Foundation Chair of Cancer Biology

MEDIA RELEASE: Dec 19, 2013 12:00 AM
Garvan is very pleased to announce that Professor Neil Watkins will assume the inaugural Petre Foundation Chair of Cancer Biology from January 2014. Professor Watkins is a clinician-scientist who currently holds the positions of Director of the Centre for Cancer Research and Professor of Cancer Biology at Monash University.

More…

Garvan announces the purchase of Irys Technology from BioNano Genomics

Garvan announces the purchase of Irys Technology from BioNano Genomics

MEDIA RELEASE: Dec 04, 2013 04:05 PM
Garvan today announced that it has elected to incorporate Irys technology from BioNano Genomics into its disease research programs, with particular emphasis on improving understanding of prostate cancer. With this purchase, Garvan becomes the first Early Access user of an Irys System in Australia.

More…

Genomics expert to assume Petre Foundation Chair of Prostate Cancer Research

Genomics expert to assume Petre Foundation Chair of Prostate Cancer Research

MEDIA RELEASE: Nov 30, 2013 12:00 AM
The Garvan Institute and the University of Sydney are proud to announce that from January 2014 Professor Vanessa Hayes will assume the inaugural Petre Foundation Chair of Prostate Cancer Research. Professor Hayes heads the Laboratory for Human Comparative and Prostate Cancer Genomics at Garvan. She also holds a position as Professor of Genomic Medicine at the J. Craig Venter Institute in San Diego, California.

More…

Daniel Christ recognised with NHMRC Excellence Award

Daniel Christ recognised with NHMRC Excellence Award

Nov 28, 2013 06:00 PM
Garvan immunologist Dr Daniel Christ has been recognised by the National Health and Medical Research Council (NHMRC) as one of the top-ranked applicants in the 2012 round of grant and fellowship awards. Last night Dr Christ received his Excellence Award at the Academy of Science in Canberra. The award winners represent the top 20 out of 5236 peer reviewed applicants for funding in 2012.

More…